{{expand English|Pregabalin|date=2016 March}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 457473985
| drug_name = 普加巴林<br>(Pregabalin)
| IUPAC_name = (''S'')-3-(aminomethyl)-5-methylhexanoic acid
| image = Pregabalin.svg
| image2 = Pregabalin ball-and-stick model.png
<!--Clinical data -->
| Drugs.com = {{drugs.com|international|pregabalin}}
| licence_US= Pregabalin
| MedlinePlus = a605045
| pregnancy_AU = B3
| pregnancy_US = C
| legal_AU = S4
| legal_CA = Rx Only
| legal_UK = POM
| legal_US = Schedule V
| legal_status = Rx Only
| routes_of_administration = 口服

<!--Pharmacokinetic data -->
| bioavailability = ≥90%
| protein_bound = Nil
| metabolism = Negligible
| onset = 1.5 小時<ref name="clevelandclinicmeded.com">{{cite web|url=http://www.clevelandclinicmeded.com/medicalpubs/pharmacy/septoct2005/pregabalin.htm|title=Pharmacotherapy Update - Pregabalin (Lyrica®):Part I|publisher=}}</ref>
| metabolites = ''N''-methylpregabalin<ref name="emea-spc">{{cite web |title=Summary of product characteristics |url=http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000546/WC500046602.pdf |date=6 March 2013 |publisher=European Medicines Agency |accessdate=6 May 2013}}</ref>
| elimination_half-life = 6.3 小時<ref name="clevelandclinicmeded.com"/>
| excretion = [[腎|腎]]

<!--Identifiers -->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 148553-50-8
| ATC_prefix = N03
| ATC_suffix = AX16
| PubChem = 5486971
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 64356
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00230
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4589156
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 55JG375S6M
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02716
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1059
| synonyms = [[isobutane|Isobut]]yl GABA

<!--Chemical data -->
| C=8 | H=17 | N=1 | O=2
| molecular_weight = 159.23 g.mol<sup>−1</sup>
| smiles = O=C(O)C[C@H](CC(C)C)CN
| InChI = 1/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1
| InChIKey = AYXYPKUFHZROOJ-ZETCQYMHBI
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = AYXYPKUFHZROOJ-ZETCQYMHSA-N
}}
{{medical}}
'''普加巴林'''（{{lang-en|'''Pregabalin'''}}）,  是一款被用作治療[[癲癇|癲癇]],  [[神經性疼痛|神經性疼痛]],  [[纖維肌痛|纖維肌痛]], 及 [[廣泛性焦慮症|廣泛性焦慮症]]<ref>{{cite journal|last1=Frampton|first1=JE|title=Pregabalin: a review of its use in adults with generalized anxiety disorder.|journal=CNS Drugs|date=September 2014|volume=28|issue=9|pages=835–54|pmid=25149863|doi=10.1007/s40263-014-0192-0}}</ref><ref name=AHFS2015>{{cite web|title=Pregabalin|url=http://www.drugs.com/monograph/pregabalin.html|publisher=The American Society of Health-System Pharmacists|accessdate=Oct 23, 2015}}</ref> 的藥物。

普瑞巴林是[[神經傳導物質|神經傳導物質]][[γ-氨基丁酸|γ-氨基丁酸]]的衍生物，也是種強效的加巴噴丁類化合物。普瑞巴林是一種[[離子通道調節劑|離子通道調節劑]]，它具有[[止痛|止痛]]，[[抗癲癇|抗癲癇]]，和[[抗焦慮|抗焦慮]]的效果。

== 參考文獻==
{{reflist|colwidth=30em}}

==外部連結==
* [http://www.lyrica.com/ Pfizer website for Lyrica]
* [http://labeling.pfizer.com/ShowLabeling.aspx?id=561 U.S. prescribing information]
* [http://www.webmd.com/drugs/drug-93965-Lyrica+Oral.aspx?drugid=93965&drugname=Lyrica+Oral Lyrica Oral at WebMD.com]
* [https://www.erowid.org/pharms/pregabalin/ Erowid Lyrica (Pregabalin) Vault]

{{Neuropathic pain and fibromyalgia pharmacotherapies}}
{{Insomnia pharmacotherapies}}
{{Anxiolytics}}
{{OCD pharmacotherapies}}
{{Hypnotics and sedatives}}
{{Anticonvulsants}}
{{GABAergics}}
{{Drug use}}
{{通道阻滞剂}}

[[分類:γ-胺基酸|分類:γ-胺基酸]]
[[分類:止痛药|分類:止痛药]]
[[分類:抗痉挛药物|分類:抗痉挛药物]]
[[分類:抗焦虑药|分類:抗焦虑药]]
[[分類:氨基丁酸类似物|分類:氨基丁酸类似物]]
[[分類:钙通道阻滞药|分類:钙通道阻滞药]]
[[分類:輝瑞產品|分類:輝瑞產品]]